<?xml version="1.0" encoding="UTF-8"?>
<ref id="B67-biomedicines-08-00060">
 <label>67.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Delwar</surname>
    <given-names>Z.M.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Kuo</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Bu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Rennie</surname>
    <given-names>P.S.</given-names>
   </name>
   <name>
    <surname>Jia</surname>
    <given-names>W.W.</given-names>
   </name>
  </person-group>
  <article-title>Tumour-specific triple-regulated oncolytic herpes virus to target glioma</article-title>
  <source>Oncotarget</source>
  <year>2016</year>
  <volume>7</volume>
  <fpage>28658</fpage>
  <lpage>28669</lpage>
  <pub-id pub-id-type="doi">10.18632/oncotarget.8637</pub-id>
  <pub-id pub-id-type="pmid">27070093</pub-id>
 </element-citation>
</ref>
